Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Programmed Cell Death-Ligand 1 in Head and Neck Squamous Cell Carcinoma: Molecular Insights, Preclinical and Clinical Data, and Therapies
Piero Giuseppe Meliante, Christian Barbato, Federica Zoccali, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15384-15384
Open Access | Times Cited: 15

Showing 15 citing articles:

The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer—Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy
Katarzyna Starska
Cancers (2023) Vol. 15, Iss. 6, pp. 1642-1642
Open Access | Times Cited: 19
Immunotherapy in Head and Neck Cancer: Where Do We Stand?
Natalia G. Vallianou, Angelos Evangelopoulos, Dimitris Kounatidis, et al.
Current Oncology Reports (2023) Vol. 25, Iss. 8, pp. 897-912
Closed Access | Times Cited: 17
Diagnostic Predictors of Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
Piero Giuseppe Meliante, Federica Zoccali, Marco de Vincentiis, et al.
Diagnostics (2023) Vol. 13, Iss. 5, pp. 862-862
Open Access | Times Cited: 15
Role of PD‐1 in Skin Cancer: Molecular Mechanism, Clinical Applications, and Resistance
Neha Sharma, Rupa Mazumder, Pallavi Rai, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 3
Closed Access | Times Cited: 2
PD-1 and PD-L1 Expression Levels as a Potential Biomarker of Chronic Rhinosinusitis and Head and Neck Cancers
Katarzyna Malinowska, Andrzej Kowalski, Anna Merecz-Sadowska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 2033-2033
Open Access | Times Cited: 7
Mechanisms of Resistance and Therapeutic Perspectives in Immunotherapy for Advanced Head and Neck Cancers
Andrew Meci, Neerav Goyal, Guy Slonimsky
Cancers (2024) Vol. 16, Iss. 4, pp. 703-703
Open Access | Times Cited: 1
Serine and one-carbon metabolism sustain non-melanoma skin cancer progression
Angela Cappello, Alessandro Zuccotti, Mara Mancini, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 4
The Impact of ROS and NGF in the Gliomagenesis and their Emerging Implications in the Glioma Treatment
Francesca Fanfarillo, Giampiero Ferraguti, Marco Lucarelli, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 4, pp. 449-462
Closed Access | Times Cited: 3
Head and Neck Squamous Cell Carcinoma Vaccine: Current Landscape and Perspectives
Piero Giuseppe Meliante, Carla Petrella, Marco Fiore, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 9215-9233
Open Access | Times Cited: 3
Co-inhibition of adenosine 2b receptor and programmed death-ligand 1 promotes the recruitment and cytotoxicity of natural killer cells in oral squamous cell carcinoma
Bing Wang, Tao Wang, Chengzhe Yang, et al.
PeerJ (2023) Vol. 11, pp. e15922-e15922
Open Access | Times Cited: 2
Overcoming Resistance to Standard-of-Care Therapies for Head and Neck Squamous Cell Carcinomas
Chester Gauss, Logan D. Stone, Mehrnoosh Ghafouri, et al.
Cells (2024) Vol. 13, Iss. 12, pp. 1018-1018
Open Access
Inhibition of ATM or ATR in combination with hypo-fractionated radiotherapy leads to a different immunophenotype on transcript and protein level in HNSCC
Julia Meidenbauer, M Wächter, Sebastian Schulz, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Advances in Immunotherapy and Innovative Therapeutic Approaches for Cancer Treatment: Editorial to the Special Issue “State-of-the-Art Molecular Oncology in Italy”
Federica Laudisi, Carmine Stolfi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8929-8929
Open Access | Times Cited: 1
Antioxidant Use after Diagnosis of Head and Neck Squamous Cell Carcinoma (HNSCC): A Systematic Review of Application during Radiotherapy and in Second Primary Cancer Prevention
Piero Giuseppe Meliante, Carla Petrella, Marco Fiore, et al.
Antioxidants (2023) Vol. 12, Iss. 9, pp. 1753-1753
Open Access | Times Cited: 1
Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells
Fridolin Grottker, Simon Gehre, Clara M. Reichardt, et al.
Neoplasia (2023) Vol. 45, pp. 100944-100944
Open Access | Times Cited: 1
Page 1

Scroll to top